Clopidogrel carboxylic acid, racemic mixture 13C6

[13C6]-Clopidogrel carboxylic acid, racemic mixture is a chemical compound that is used in the pharmaceutical industry for the treatment of cardiovascular diseases. It is a labeled compound, which means that six carbon atoms have been replaced with the isotope carbon-13 for tracking purposes. The racemic mixture indicates that it is a combination of two enantiomers, which are mirror images of each other, but have different chemical properties. Clopidogrel carboxylic acid is a metabolite of the drug clopidogrel, which is used to prevent blood clots in patients with a history of heart attacks, strokes, or peripheral arterial disease. By inhibiting platelet aggregation, clopidogrel and its metabolites reduce the risk of thrombotic events. The labeled compound [13C6]-Clopidogrel carboxylic acid is used in research and clinical studies to track the metabolism and pharmacokinetics of clopidogrel in vivo. Its presence can be detected and quantified using mass spectrometry, which allows for a better understanding of the drug's efficacy and safety. Chemically, [13C6]-Clopidogrel carboxylic acid has a molecular formula of C16H12ClNO4S and a molecular weight of 365.79 g/mol. It is a white to off-white crystalline powder with a melting point of approximately 170°C. Its solubility in water is limited, but it is soluble in organic solvents such as methanol and dimethyl sulfoxide. In conclusion, [13C6]-Clopidogrel carboxylic acid, racemic mixture is a useful tool for studying the pharmacokinetics of clopidogrel and its metabolites. Its labeled carbon atoms allow for easy tracking and detection, while its racemic mixture provides insight into the behavior of the two enantiomers.